Friday, November 29, 2019

Catalysts Aplenty For Can-Fite (CANF)

Can-Fite BioPharma Ltd. (CANF), a biotechnology company developing drugs that address cancer, liver and inflammatory diseases, looks forward to several milestones in 2020.

from RTT - Biotech https://ift.tt/2DpEsHk
via IFTTT
Read More »

Rising Tensions In Hong Kong May Lead To Pullback On Wall Street

The major U.S. index futures are currently pointing to a lower opening on Friday, with stocks likely to move back to the downside after trending higher in recent sessions.

from RTT - Market Analysis https://ift.tt/33tPc1J
via IFTTT
Read More »

Daily Mail owner buys the i newspaper for £49.6m

DMGT will integrate some operations but appears to rule out editorial job cuts

The owner of the Daily Mail has bought the i newspaper and website for £49.6m as a new wave of media consolidation hits the UK national and regional newspaper market.

Daily Mail and General Trust (DMGT), which also owns the Mail on Sunday and Mail Online, had been the frontrunner to seal a deal after entering exclusive talks with the i’s parent, JPI Media, in September.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2Dyx38p
Read More »

Wednesday, November 27, 2019

Inspire Medical Systems On A Roll...

Shares of Inspire Medical Systems Inc. (INSP) hit a new high in intraday trading today and are currently at $71.

from RTT - Biotech https://ift.tt/2DlhxNf
via IFTTT
Read More »

Upward Momentum May Lead To Continued Strength On Wall Street

The major U.S. index futures are pointing to a modestly higher opening on Wednesday, with stocks likely to extend the upward move seen over the past few sessions.

from RTT - Market Analysis https://ift.tt/2OqchOU
via IFTTT
Read More »

Did Global Cord Blood (CO) Catch Your Eye?

Shares of Global Cord Blood Corp. (CO) are down nearly 37% from their 52-week high of $7.73 recorded on March 1, 2019.

from RTT - Biotech https://ift.tt/2XQj7jD
via IFTTT
Read More »

Tuesday, November 26, 2019

Will Third Time Prove A Charm For Baudax Bio?

Baudax Bio Inc., a spinoff from Recro Pharma Inc (REPH), began trading on the NASDAQ Capital Market under the ticker symbol "BXRX" on November 22, 2019. The shares have gained more than 50 percent over the last three trading days.

from RTT - Biotech https://ift.tt/2OMDkTs
via IFTTT
Read More »